Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with
motor neuron degeneration, muscle weakness, paralysis and finally death. The proposed …

Amyotrophic lateral sclerosis (ALS) is the most frequently occurring of the neuromuscular
degenerative disorders, with a median survival time of 3–5 years. The pathophysiological …

Genetic insights into the pathophysiology of amyotrophic lateral sclerosis (ALS) are
untangling the clinical heterogeneity that may contribute to poor clinical trial outcomes and …

Amyotrophic lateral sclerosis (ALS) is one of the most common neurodegenerative diseases,
characterized by inevitable progressive paralysis. To date, only two disease modifying …

Amyotrophic lateral sclerosis (ALS) is a terminal late-onset condition characterized by the
loss of upper and lower motor neurons. Mutations in more than 30 genes are associated to …

Amyotrophic lateral sclerosis (ALS) is a devastating and incurable neurodegenerative
disease characterized by the progressive loss of upper and lower motor neurons. ALS …

Amyotrophic lateral sclerosis (ALS) is an adult onset disorder characterized by progressive
neuromuscular junction (NMJ) dismantling and degeneration of motor neurons leading to …

Amyotrophic lateral sclerosis (ALS) is one of the most complex motor neuron diseases. Even
though scientific discoveries are accelerating with an unprecedented pace, to date more …

Amyotrophic lateral sclerosis (ALS) is a disorder that involves the degeneration of motor
neurons, muscle atrophy, and paralysis. In a few familiar forms of ALS, mutations in the …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that results in
progressive loss of bulbar and limb function. Patients typically die from respiratory failure …